APA (7th ed.) Citation

H, Z., C, L., S, L., Y, T., S, S., F, Y., . . . Z, W. (2022). PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer. Cancer biology & therapy, 23(1), 1. https://doi.org/10.1080/15384047.2022.2125260

Chicago Style (17th ed.) Citation

H, Zhang, Li C, Liao S, Tu Y, Sun S, Yao F, Li Z, and Wang Z. "PSMD12 Promotes the Activation of the MEK-ERK Pathway by Upregulating KIF15 to Promote the Malignant Progression of Liver Cancer." Cancer Biology & Therapy 23, no. 1 (2022): 1. https://doi.org/10.1080/15384047.2022.2125260.

MLA (9th ed.) Citation

H, Zhang, et al. "PSMD12 Promotes the Activation of the MEK-ERK Pathway by Upregulating KIF15 to Promote the Malignant Progression of Liver Cancer." Cancer Biology & Therapy, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1080/15384047.2022.2125260.